Primary care headache care now hinges on matching treatment to the patient’s broader disease burden
Headache is one of the most common reasons adults seek primary care, yet treatment often becomes fragmented when clinicians chase pain alone and miss the conditions shaping it. This narrative review argues for a different approach: confirm the headache phenotype, screen for secondary causes, identify comorbidities, and choose therapies that can treat more than one problem at a time.
The logic is straightforward. When a patient has headache plus hypertension, depression, insomnia, obesity, or another chronic disorder, a single medication may do more than reduce pain. It can also reduce medication burden, limit interaction risk, and improve adherence because the treatment plan feels clinically coherent rather than layered and improvised. The review emphasizes that this kind of comorbidity-aligned care belongs in primary care, not only in specialty headache clinics.
Phenotype first, because the wrong diagnosis leads to the wrong therapy
The starting point remains clinical classification. A primary care clinician has to determine whether the patient’s symptoms fit a primary headache disorder or raise concern for a secondary cause. That step shapes every subsequent decision, from imaging to drug choice to the need for urgent referral.
Once the phenotype is clear, the therapeutic goal is not simply to suppress pain for a few hours. It is to match the medication strategy to the full clinical picture. Patients with recurrent headache and coexisting disease often receive multiple prescriptions from different clinicians, and each additional drug increases the chance of confusion, side effects, and nonadherence. A streamlined regimen matters because headache care is often long term, and long-term treatment fails quickly when patients cannot tolerate the plan or understand why each medication is there.
Therapies that serve two conditions can reduce medication stacking
A central theme of the review is the value of treatments that address headache and a coexisting disorder simultaneously. In practice, this means selecting medications with a broader clinical fit when evidence and contraindications allow. For some patients, that can reduce the need to add separate agents for blood pressure, mood, sleep, or other chronic problems.
This is not a theoretical preference for elegance. Polypharmacy changes the risk profile at the bedside. More medications create more opportunities for adverse effects, drug-drug interactions, and dose adjustments that never quite settle into a stable routine. A comorbidity-aligned regimen can simplify the day-to-day reality of care, especially in adults who already manage several chronic illnesses and may struggle to keep up with complex instructions.
Headache treatment also becomes more durable when the chosen therapy fits the patient’s expectations and routine. Adherence improves when a patient can see that the medication has a role beyond pain relief alone. In that sense, therapeutic alignment is a practical strategy for persistence, not just a neat pharmacologic concept.
Non-pharmacologic treatment belongs in the main plan, not as an afterthought
Lifestyle-based and behavioral measures remain a core part of management. The review places non-pharmacologic interventions alongside medication selection rather than treating them as optional extras. That framing reflects clinical reality: headache frequency and severity are often shaped by sleep disruption, stress, hydration, activity patterns, and other modifiable factors that medicines alone cannot correct.
Structured follow-up matters here. Headache care changes over time, and the best regimen at one visit may fail later because triggers change, comorbidities evolve, or acute medication use begins to drift upward. Reassessment gives clinicians a chance to refine the diagnosis, check for medication overuse, and decide whether a different preventive strategy is needed. Without that loop, primary care can drift into repeated prescribing without real control of the disorder.
Medication-overuse headache can quietly sabotage otherwise reasonable care
Medication overuse occupies a special place in headache management because it can transform a treatable disorder into a self-perpetuating one. Frequent use of acute therapies may blunt short-term pain while worsening the overall pattern of headache over time. Recognition of this cycle is essential, because no preventive plan can work well if the acute regimen is driving the problem.
This review treats medication overuse as a clinical target in its own right. That approach is important in primary care, where patients may be taking analgesics, combination products, or migraine-directed agents without a clear understanding of frequency limits. Once overuse is identified, care has to shift from repeated rescue treatment to a structured reset, paired with prevention and education. The therapeutic challenge is not only choosing the right drug; it is stopping the wrong pattern of use.
Office-based procedures have a role, but evidence and skill still set the boundaries
Selected office-based procedures may offer additional treatment options for appropriately chosen patients. Their place in care depends on patient selection, evidence quality, and clinician competence. The review does not present these procedures as universal solutions; instead, it positions them as part of a broader toolkit that should be used judiciously.
For primary care clinicians, this creates a clear boundary. Procedural care can expand access and help certain patients when medication strategies are inadequate or poorly tolerated, but the technique must be evidence-informed and performed competently. A procedure that is poorly matched to the headache type, or delivered without attention to training and safety, can add risk without solving the underlying disorder.
A practical framework for headache care that fits the realities of primary care
The review’s most useful contribution is its insistence that headache management should be individualized without becoming chaotic. Confirm the diagnosis. Screen for secondary causes. Identify the illnesses already shaping the patient’s life. Choose therapies that can address both headache and comorbidity when possible. Add non-pharmacologic strategies early. Revisit medication use over time so overuse does not undermine progress.
For adults with chronic headache, this model can make treatment feel more connected and less burdensome. It also keeps primary care centered in a condition that is often chronic, recurrent, and intimately tied to the rest of the patient’s health. The review does not provide a new trial endpoint or a single breakthrough drug. Instead, it offers a practice framework built around evidence synthesis, clinical judgment, and the real-world problem of managing multiple conditions without drowning the patient in prescriptions.
The review is also limited by its design. As a narrative synthesis, it depends on targeted literature searches and guideline integration rather than prospective testing in a single cohort. It was not prospectively registered. Even so, the clinical message is direct: headache treatment in primary care works best when the plan is built around the whole patient, not the headache alone.